講演・口頭発表等 - 原田　浩之

81. Shunsuke ITAI, Tomokazu OHISHI, Mika K. KANEKO, Shinji YAMADA, Shinji ABE, Yasuhiko NISHIOKA, Hiroyuki HARADA, Yukinari KATO. Antitumor activity by ADCC against oral squamous cell carcinomas by anti-podocalyxin antibody. 第77回日本癌学会学術総会 2018.09.27 大阪

82. Namiaki TAKAHARA, Atsushi KIMURA, Yusuke HIGUCHI, Yuji KABASAWA, Tetsuya YODA, Hiroyuki HARADA. Evaluation Of Postoperative Mandibular Stability After Bimaxillary Surgery For Mandibular Setback And The Clockwise Rotation Of The Proximal Segment. 24th Congress of the European Association for Cranio Maxillo Facial Surgery 2018.09.18 Munich(Germany)

83. 板井 俊介, 大石 智一, 金子 美華, 山田 慎二, 阿部 真治, 西岡 安彦, 川田 学, 原田 浩之, 加藤 幸成. 口腔扁平上皮癌における抗ポドカリキシン抗体のADCCによる抗腫瘍効果(Antitumor activity by ADCC against oral squamous cell carcinomas by anti-podocalyxin antibody). 日本癌学会総会記事 2018.09.01

84. 高川 祐希, 玄 泰行, 村松 智輝, 原田 浩之, 稲澤 譲治. 口腔扁平上皮癌における新規のがん抑制型マイクロRNAの探索(Exploring novel tumor suppressive microRNAs in OSCC). 日本癌学会総会記事 2018.09.01

85. Kaifeng LUO, Yutaka MARUOKA, Rie KINOSHITA, Teru OKITSU, Libo WU, Nobuyuki TAKAMA, Beomjoon KIM. Study on the use of dissolvable microneedles in the treatment of stomatitis. The International Symposium on Precision Engineering and Sustainable Manufacturing (PRESM 2018) 2018.07.03 札幌

86. Naoto NISHII, Hidetake TACHINAMI, Yuta KONDO, Yulong XIA, Yoshihisa KASHIMA, Tatsukuni OHNO, Shigenori NAGAI, Lixin LI, Walter LAU, Hiroyuki HARADA and Miyuki AZUMA. Systemic administration of a TLR7 agonist attenuates regulatory T cells by dendritic cell modification and overcomes resistance to PD-L1 blockade therapy. 15th International symposium on dendritic cells 2018.06.09 Aachen (Germany)

87. Shunsuke ITAI, Mika K. KANEKO, Shinji YAMADA, Yukinari KATO. A core fucose-deficient anti-podocalyxin antibody exhibits anti-tumor activity via augmented antibody-dependent cellular cytotoxicity in oral squamous cell　carcinoma. America association for cancer research(2018) 2018.04.18 Chicago(USA)

88. Yukinobu TAKAHASHI, Eriko MARUKAWA, Hiroyuki HARADA. The use of a new porous hydroxyapatite-collagen composite in a ridge preservation. 2018 AO Annual Meeting 2018.02.28 Los Angeles(USA)

89. Nishii Naoto, Tachinami Hidetake, Yoshihisa Kashima, Kondo Yuta, Harada Hiroyuki, Azuma Miyuki. 癌免疫療法併用　免疫チェックポイント阻害薬を超えて　PD-1チェックポイント阻害抵抗性および制御性T細胞優位のマウス腫瘍モデルにおける低用量TLR7作動薬の全身投与は抗腫瘍応答を増大させる(Combination cancer immunothrapy: beyond immune checkpoint inhibitors　Systemic administration of low dose TLR7 agonist augments antitumor responses in the PD-1 checkpoint blockade-resistant and regulatory T cell-dominant murine tumor models). 日本免疫学会総会・学術集会記録 2017.12.01

90. Shimada Y, Kawasaki Y, Ide K, Sato I, Hagiwara S, Yamada H, Maruoka Y. Differential diagnosis of fever in patients with hematologic malignancy receiving chemotherapy: A retrospective cohort study in Japan. 99th the American Association of Oral and Maxillofacial Surgeons(AAOMS) Annual Meeting Oct 9-14th 2017 2017.10.09 San Francisco

91. 板井 俊介, 山田 慎二, 金子 美華, 張 耀文, 国田 朱子, 深山 正久, 原田 浩之, 加藤 幸成. 口腔がんに対する免疫染色に有用な抗ポドカリキシン抗体PcMab-47の樹立. 日本癌学会総会記事 2017.09.01

92. 高原 楠旻, 中川 聡, 角倉 可奈子, 坂本 一郎, 原田 浩之. 顎関節痛とMRI所見の関連について(Association of TMJ pain according to magnetic resonance imaging findings in TMD patients). 日本顎関節学会雑誌 2017.07.01

93. Uo M, Wada T, Komiya R, Harada H, Sakamoto K, Ikeda T, Yamaguchi A. Trace metallic element accumulation in the sequestrum of medication-related osteonecrosis of the jaw (MRONJ). 14th International Symposium on Applied Bioinorganic hemistry – ISABC14 June 7-10th 2017 2017.06.07 Toulouse, France

94. Miyazaki H，Wada Y，Tanaka K，Harada H，Asamura S. Treatment strategies for oral vascular anomalies: Approaches to massive lesions using intralesional laser photocoagulation. European Congress of Laser Dentistry, March 30-April 1 2017. 2017.03.30 Plovdiv

95. Shimada Y，Nakagawa Y，Ide K，Sato I，Hagiwara S，Yamada H，Kawasaki Y，Maruoka Y . Oral adverse event and the risk factor in patients with hematologic malignancy receiving chemotherapy: A retrospective cohort study in Japan. The 98th Annual Meeting of American Association of Oral and Maxillofacial Surgeons (AAOMS)　Sep 18-23, 2016. 2016.09 Las Vegas

96. Miyazaki H，Romeo U，Wada Y，Kato J，Tanaka K，Alessandro DV, Maruoka Y， Watanabe H，Harada H，Asamura S. Treatment strategies for large oral vascular anomalies using intralesional laser photocoagulation. The 15th Congress of the World Federation for Laser Dentistry, July 17-19 2016. 2016.07.17 Aichi

97. Hidetaka Miyazaki，Umberto Romeo，Yoshitaka Wada，Junji Kato，Kae Tanaka，Alessandro Del Vecchio，Yutaka Maruoka，Hisashi Watanabe，Hiroyuki Harada，Shinichi Asamura. Treatment strategies for large oral vascular anomalies using intralesional laser photocoagulation. The 15th Congress of the World Federation for Laser Dentistry (WFLD) Jul 17-19 2016 2016.07 Nagoya

98. Takahara N, Kabasawa Y, Tetsumura A, Kurabayashi T, Harada H. Dynamic MR imaging of the temporomandibular joint: a preliminary study. Advanced Digital Technology (ADT) North America & Japan Regional Leadership Groups Conference,June 16-20 2016. 2016.06.16 San Diego

99. Kabasawa Y, Tsuchida Y, Takahara N, Kamijo S, Suzuki T. :Accuracy of a 3D Model for Surgical Support in Orthognathic Surgery- Efficacy of Data Synthesis with Computed Tomography and Dental Model Scan-. Advanced Digital Technology (ADT) North America & Japan Regional Leadership Groups Conference, June 16-20 2016. 2016.06.16 San Diego

100. Nishii N, Kondo Y, Li L, Lau W, Hi, Harada H, Azuma M. Combined treatment with PD-L1 blockade and a TLR7/8 agonist dramatically enhances antitumor immunity. AACR2016 2016.04.16 New Orleans, LA, USA Ernest N. Morial Convention Center